{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:29:05Z","timestamp":1788398945891,"version":"build-2803163510"},"reference-count":22,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2026.13121","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T11:26:27Z","timestamp":1772537187000},"page":"1-5","source":"Crossref","is-referenced-by-count":1,"title":["Anti\u2011inflammatory effects of oridonin on an\n                    <i>in vitro<\/i>\n                    model using LPS\u2011treated human intestinal Caco\u20112 cells"],"prefix":"10.3892","volume":"31","author":[{"given":"Maonan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Rectum Surgery, Jilin Cancer Hospital, Changchun, Jilin 130000, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Rectum Surgery, Jilin Provincial People's Hospital, Changchun, Jilin 130000, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Diagnosis, School of Medical Technology, Beihua University, Jilin, Jilin 132013, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rectum Surgery, Jilin Cancer Hospital, Changchun, Jilin 130000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Diagnosis, School of Medical Technology, Beihua University, Jilin, Jilin 132013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"key20260417104453_b1-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"128","DOI":"10.15403\/jgld-5903","article-title":"Colitis trouble up high: a case of gastroduodenal ulcerative colitis and literature review","volume":"34","author":"Cauchi","year":"2025","journal-title":"J Gastrointestin Liver Dis"},{"issue":"goaf082","key":"key20260417104453_b2-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goaf082","article-title":"Global, regional, and national burden of inflammatory bowel disease from 1990 to 2021: Findings from the global burden of disease 2021","volume":"13","author":"Ruan","year":"2025","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"key20260417104453_b3-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1097\/CM9.0000000000003442","article-title":"Comparative analysis of cancer statistics in China and the United States in 2024","volume":"137","author":"Wu","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"key20260417104453_b4-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.path.2020.05.003","article-title":"Upper gastrointestinal manifestations of inflammatory bowel disease","volume":"13","author":"Harpaz","year":"2020","journal-title":"Surg Pathol Clin"},{"issue":"9344","key":"key20260417104453_b5-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169344","article-title":"Inflammatory bowel disease:A review of pre-clinical murine models of human disease","volume":"23","author":"Katsandegwaza","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1333657","key":"key20260417104453_b6-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1333657","article-title":"Natural compounds target programmed cell death (PCD) signaling mechanism to treat ulcerative colitis: A review","volume":"l15","author":"Chen","year":"2024","journal-title":"Front Pharmaco"},{"issue":"779177","key":"key20260417104453_b7-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.779177","article-title":"SIRT1: A potential therapeutic target in autoimmune diseases","volume":"12","author":"Shen","year":"2021","journal-title":"Front Immunol"},{"key":"key20260417104453_b8-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cca.2015.12.004","article-title":"Circulating autoantibodies in cancer patients have high specificity for glycoxidation modified histone H2A","volume":"453","author":"Mir","year":"2016","journal-title":"Clin Chim Acta"},{"key":"key20260417104453_b9-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.1038\/s41388-022-02447-y","article-title":"Nucleolar protein NOC4L inhibits tumorigenesis and progression by attenuating SIRT1-mediated p53 deacetylation","volume":"41","author":"Jia","year":"2022","journal-title":"Oncogene"},{"key":"key20260417104453_b10-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.2174\/0113816128318032240702045822","article-title":"Maximizing treatment options for IBD through drug repurposing","volume":"30","author":"Barjasteh","year":"2024","journal-title":"Curr Pharm Des"},{"issue":"332","key":"key20260417104453_b11-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25020332","article-title":"Solubility and bioavailability enhancement of oridonin: A review","volume":"25","author":"Zhang","year":"2020","journal-title":"Molecules"},{"issue":"645824","key":"key20260417104453_b12-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.645824","article-title":"Oridonin: A review of its pharmacology, pharmacokinetics and toxicity","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"issue":"312","key":"key20260417104453_b13-ETM-31-5-13121","article-title":"Oridonin attenuates dextran sulfate sodium-induced ulcerative colitis in mice via the Sirt1\/NF-\u03baB\/p53 pathway","volume":"26","author":"Wang","year":"2022","journal-title":"Mol Med Rep"},{"key":"key20260417104453_b14-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.ijbiomac.2016.02.015","article-title":"Chitosan nanoparticles reduce LPS-induced inflammatory reaction via inhibition of NF-\u03baB pathway in Caco-2 cells","volume":"86","author":"Tu","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"101921","key":"key20260417104453_b15-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2020.101921","article-title":"Bergenin-activated SIRT1 inhibits TNF-\u03b1-induced proinflammatory response by blocking the NF-\u03baB signaling pathway","volume":"62","author":"Chen","year":"2020","journal-title":"Pulm Pharmacol Ther"},{"issue":"115388","key":"key20260417104453_b16-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115388","article-title":"Oridonin alleviates SiNPs-induced pulmonary fibrosis by inhibiting pyroptosis via IRE1\u03b1-XBP1s-NLRP3 pathway","volume":"164","author":"Ban","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"key20260417104453_b17-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s10753-020-01364-0","article-title":"Oridonin attenuates TNBS-induced post-inflammatory irritable bowel syndrome via PXR\/NF-\u03baB signaling","volume":"44","author":"Shao","year":"2021","journal-title":"Inflammation"},{"issue":"831168","key":"key20260417104453_b18-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","article-title":"Regulation of SIRT1 and its roles in inflammation","volume":"13","author":"Yang","year":"2022","journal-title":"Front Immunol"},{"issue":"155179","key":"key20260417104453_b19-ETM-31-5-13121","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155179","article-title":"The bioavailability enhancement and insight into the action mechanism of poorly soluble natural compounds from co-crystals preparation: Oridonin as an example","volume":"122","author":"Jia","year":"2024","journal-title":"Phytomedicine"},{"key":"key20260417104453_b20-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"68153","DOI":"10.18632\/oncotarget.19249","article-title":"Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"key":"key20260417104453_b21-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0169-409x(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"key20260417104453_b22-ETM-31-5-13121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol Toxicol"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T07:45:48Z","timestamp":1776411948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2026.13121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2026.13121","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]}}}